Seed · Biotech · Cambridge, United Kingdom · Founded 2020 · 11–50 employees
Clock Health operates a scientific platform designed for human cellular rejuvenation and healthspan extension. By force-aging human induced pluripotent stem cells, the company triggers natural self-rejuvenation programs to model biological aging. Utilizing genome-wide CRISPR screens and single-cell RNA sequencing, they decoded these cellular mechanisms to build an Atlas of Rejuvenation Factors with over 140 candidate genes. Their initial commercial strategy targets topical skin rejuvenation and nutraceuticals, ahead of complex clinical therapeutics. Following an administration restructuring in early 2026, the company's assets were acquired by co-founder Dr. Mark Kotter to continue its research operations.
No open roles listed right now.